Axxcess Wealth Management LLC decreased its holdings in Markel Group Inc. (NYSE:MKL – Free Report) by 0.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 871 shares of the insurance provider’s stock after selling 7 shares during the period. Axxcess Wealth Management LLC’s holdings in Markel Group were worth $1,740,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Markel Group in the first quarter worth about $115,000. GAMMA Investing LLC increased its stake in shares of Markel Group by 12.7% in the first quarter. GAMMA Investing LLC now owns 62 shares of the insurance provider’s stock worth $116,000 after purchasing an additional 7 shares in the last quarter. Vontobel Holding Ltd. purchased a new position in shares of Markel Group in the first quarter worth about $372,000. Check Capital Management Inc. CA increased its stake in shares of Markel Group by 2.5% in the first quarter. Check Capital Management Inc. CA now owns 79,086 shares of the insurance provider’s stock worth $147,860,000 after purchasing an additional 1,921 shares in the last quarter. Finally, Values Added Financial LLC increased its stake in shares of Markel Group by 42.0% in the first quarter. Values Added Financial LLC now owns 1,511 shares of the insurance provider’s stock worth $2,825,000 after purchasing an additional 447 shares in the last quarter. Hedge funds and other institutional investors own 77.12% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently commented on MKL shares. Cowen reaffirmed a “hold” rating on shares of Markel Group in a research note on Tuesday, October 7th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Markel Group in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Markel Group presently has an average rating of “Hold” and a consensus target price of $1,930.50.
Markel Group Trading Down 2.0%
Shares of MKL opened at $1,916.70 on Thursday. The firm has a market cap of $24.25 billion, a price-to-earnings ratio of 11.50 and a beta of 0.78. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.59 and a current ratio of 0.59. Markel Group Inc. has a fifty-two week low of $1,521.25 and a fifty-two week high of $2,075.92. The firm has a 50 day moving average price of $1,937.77 and a 200-day moving average price of $1,916.53.
Markel Group (NYSE:MKL – Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $25.46 earnings per share for the quarter, topping analysts’ consensus estimates of $24.74 by $0.72. The firm had revenue of $4.82 billion during the quarter, compared to analyst estimates of $3.96 billion. Markel Group had a net margin of 13.39% and a return on equity of 7.18%. The business’s quarterly revenue was up 24.3% on a year-over-year basis. During the same period in the previous year, the business posted $18.62 EPS. As a group, equities research analysts forecast that Markel Group Inc. will post 96.25 earnings per share for the current year.
Markel Group Company Profile
Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.
Further Reading
- Five stocks we like better than Markel Group
- ESG Stocks, What Investors Should Know
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- What is a Bond Market Holiday? How to Invest and Trade
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Group Inc. (NYSE:MKL – Free Report).
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.